>>Signaling Pathways>> Chromatin/Epigenetics>> Epigenetic Reader Domain>>IACS-9571 (ASIS-P040)

IACS-9571 (ASIS-P040) (Synonyms: ASIS-P040)

Catalog No.GC33042

IACS-9571 (ASIS-P040)는 TRIM24 및 BRPF1의 강력하고 선택적인 억제제로, TRIM24에 대한 IC50는 8 nM이며, TRIM24 및 BRPF1에 대한 Kd는 각각 31 nM 및 14 nM입니다.

Products are for research use only. Not for human use. We do not sell to patients.

IACS-9571 (ASIS-P040) Chemical Structure

Cas No.: 1800477-30-8

Size 가격 재고 수량
1mg
US$110.00
재고 있음
5mg
US$321.00
재고 있음
10mg
US$597.00
재고 있음
50mg
US$2,068.00
재고 있음
100mg
US$3,033.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

IACS-9571 is a potent and selective inhibitor of TRIM24 and BRPF1, with IC50 of 8 nM for TRIM24, and Kds of 31 nM and 14 nM for TRIM24 and BRPF1, respectively.

IACS-9571 shows excellent cellular potency with EC50 of 50 nM. IACS-9571 (1 μM) has potent activities against a panel of 32 bromodomains. IACS-9571 is a selective dual TRIM24/BRPF1 inhibitor (Kd = 1.3/2.1 nM) with 9- and 21-fold selectivity against BRPF2 and BRPF3, respectively. IACS-9571 does not interact with the BET sub-family of bromodomains, displaying greater than 7,700-fold selectivity versus BRD4(1, 2) relative to TRIM24[1].

[1]. Palmer WS, et al. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor. J Med Chem. 2016 Feb 25;59(4):1440-54.

리뷰

Review for IACS-9571 (ASIS-P040)

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for IACS-9571 (ASIS-P040)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.